Glycomet Metformin SR 500 mg tablet 10x10 tablets supports adults managing type 2 diabetes by improving insulin sensitivity and reducing hepatic glucose production. This extended-release formulation promotes more stable blood glucose control with a lower risk of gastrointestinal side effects than immediate-release options.
With clear dosing guidance, structured monitoring, and healthcare provider oversight, this medication plays a central role in long-term cardiometabetes management. The following sections outline key usage patterns, safety considerations, and practical patient information tailored to real-world use.
| Product Name | Strength | Pack Size | Primary Use |
|---|---|---|---|
| Glycomet Metformin SR | 500 mg | 10x10 tablets (100 tablets total) | Type 2 diabetes management |
| Release Type | Extended-Release (SR) | Once-daily dosing | Improved gastric tolerability |
| Therapeutic Class | Biguanide | First-line therapy | Improves peripheral insulin sensitivity |
| Prescription Status | Rx-only | Requires medical supervision | Regular renal and metabolic monitoring |
Dosing Guidelines Glycomet Metformin SR 500 mg
Clinicians typically initiate Glycomet Metformin SR 500 mg once daily with the evening meal to minimize gastrointestinal disturbance. Titration is gradual, often increasing by 500 mg weekly based on tolerance and fasting glucose targets, up to a usual maximum of 2000 mg per day.
Renal function assessments are essential before initiation and at least annually thereafter, as metformin clearance depends on adequate kidney function. Dose adjustments are mandatory for eGFR below 45 mL/min/1.73 m², and the tablet should be swallowed whole with water to preserve the extended-release properties.
Mechanism of Action in Type 2 Diabetes
Glycomet Metformin SR 500 mg primarily reduces hepatic gluconeogenesis and enhances peripheral glucose uptake in muscle tissue. Unlike sulfonylureas, it does not stimulate insulin secretion, which lowers the risk of hypoglycaemia when used as monotherapy.
By activating AMP-activated protein kinase, the medication modulates cellular energy homeostasis and improves insulin sensitivity over time. These effects contribute to lower fasting plasma glucose and HbA1c without promoting weight gain, and often supporting modest weight loss.
Safety Monitoring and Contraindications
Pregnancy category B in many regions supports cautious use when benefits outweigh risks, yet lactation and paediatric use remain under careful professional guidance. Acute or chronic metabolic acidosis, severe renal impairment, and hypersensitivity to metformin are definitive contraindications requiring avoidance of Glycomet Metformin SR 500 mg.
Contrast imaging with iodinated materials may necessitate temporary discontinuation to reduce the risk of lactic acidosis, particularly in patients with unstable renal function. Regular laboratory checks of renal and hepatic parameters, along with vitamin B12 monitoring over long-term use, help maintain an optimal safety profile.
Side Effects and Patient Management
Gastrointestinal complaints such as nausea, metallic taste, and mild diarrhoea are common early on and often diminish by titrating the dose and taking the tablet with food. Transient vitamin B12 malabsorption may develop after several years, warranting periodic assessment especially in those with borderline nutritional status.
Lactic acidosis, though rare, presents with nonspecific symptoms like malaise, myalgia, and respiratory distress and requires urgent medical evaluation. Recognizing early intolerance and coordinating with a healthcare provider ensures timely dose adjustments or formulation switches when necessary.
Long-Term Management with Glycomet Metformin SR 500 mg
Regular HbA1c testing, renal function monitoring, and open communication with your healthcare team help ensure that Glycomet Metformin SR 500 mg tablet 10x10 tablets remains a safe and effective component of your type 2 diabetes plan. Adherence to prescribed dosing and lifestyle recommendations supports durable metabolic control and reduces long-term complications.
- Initiate at the recommended dose and titrate gradually to improve tolerance.
- Monitor renal function regularly and adjust dose in accordance with eGFR.
- Take the tablet whole with food to minimize gastrointestinal upset.
- Discuss imaging procedures and surgeries with your clinician regarding metformin use.
- Combine medication adherence with diet, exercise, and self-monitoring for optimal control.
FAQ
Reader questions
How should I take Glycomet Metformin SR 500 mg tablet 10x10 tablets for type 2 diabetes?
Take one 500 mg tablet once daily with your evening meal, swallowing it whole with water. Do not crush or chew the tablet, and follow any personalized schedule your healthcare provider has prescribed.
What should I do if I miss a dose of Glycomet Metformin SR 500 mg?
If you remember soon after the usual dosing time, take the missed tablet with food and continue your regular schedule. If it is nearly time for the next dose, skip the missed one and resume normal timing; never double up to compensate.
Can I continue Glycomet Metformin SR 500 mg before a contrast scan or surgery?
Inform your clinician and radiology team about metformin use; they may instruct you to pause the medication on the day of the procedure and for 48 hours afterward, depending on renal function and contrast type.
What lifestyle measures support glycaemic control while using Glycomet Metformin SR 500 mg tablet 10x10 tablets?
Adopt a balanced diet low in refined carbohydrates, engage in regular moderate-intensity exercise, maintain a healthy weight, avoid excessive alcohol, and monitor blood glucose as advised to enhance the effectiveness of treatment.